Conversely, the significant downregulation of MAP2K6, ABCC2, and MDGA suggests impaired MAPK signaling, which may affect tumor cell proliferation, differentiation, and drug resistance (76, 77). This evidence concerns the gene ABCC2 and neoplasm.